Alberto Grassini

Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study

A. Brusco, I. Rainero, E. Rubino, 2022, Neurobiology of pain.

Synaptic Proteins as Fluid Biomarkers in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

A. Vercelli, I. Rainero, E. Rubino, 2022, Journal of Alzheimer's disease : JAD.

Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report

M. Bozzali, M. Cercignani, D. Garbossa, 2021, Neurological Sciences.

Impact of COVID-19 on chronic migraine treated with erenumab: a case report

I. Rainero, E. Rubino, S. Boschi, 2021, Neurological Sciences.

Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?

I. Rainero, E. Rubino, S. Boschi, 2022, Brain sciences.

Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks

I. Rainero, E. Rubino, S. Boschi, 2022, International journal of molecular sciences.

A Novel PSEN1 Variant Leading to Posterior Cortical Atrophy: A Case Report

P. Dentelli, B. Pasini, A. Brusco, 2023, Journal of Alzheimer's disease reports.

Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study

I. Rainero, E. Rubino, S. Boschi, 2022, Heliyon.

Is headache a risk factor for dementia? A systematic review and meta-analysis

I. Rainero, E. Rubino, S. Boschi, 2023, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

Aquaporin-4 as an early cerebrospinal fluid biomarker of Alzheimer's disease

Alberto Grassini, PhD Nerea Gómez de San José, PhD Steffen Halbgebauer, 2024, medRxiv.